MedPath

Effect of diazepam and haloperidol in controlling agitatio

Early Phase 1
Recruiting
Conditions
poisoned patients.
F00-F99
Registration Number
IRCT20210720051946N6
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria include consent to participate in the study, diagnosis of agitation with DSM 5 1 criteria following the consumption of stimulants and age over 18 years.

Exclusion Criteria

On the other hand, another set of indicators is considered as exclusion criteria, these exclusion criteria include lack of consent to participate in the study, the presence of risk factors for cognitive disorders such as the presence of brain and nerve diseases (such as seizures, dementia, Parkinson's). ), a history of moderate to severe head trauma, a history of head trauma, decreased level of consciousness, glaucoma, psychosis, moderate to severe dependence on other substances, heart diseases such as long QT 2, and observation of the side effects of the drugs used.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agitation. Timepoint: 0,10,15,30 min. Method of measurement: richmond questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath